Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

Background: Up-to-date evidence on levels and trends for age-sex-specific all-cause and cause-specific mortality is essential for the formation of global, regional, and national health policies. In the Global Burden of Disease Study 2013 (GBD 2013) we estimated yearly deaths for 188 countries between 1990, and 2013. We used the results to assess whether there is epidemiological convergence across countries. Methods We estimated age-sex-specific all-cause mortality using the GBD 2010 methods with some refinements to improve accuracy applied to an updated database of vital registration, survey, and census data. We generally estimated cause of death as in the GBD 2010. Key improvements included the addition of more recent vital registration data for 72 countries, an updated verbal autopsy literature review, two new and detailed data systems for China, and more detail for Mexico, UK, Turkey, and Russia. We improved statistical models for garbage code redistribution. We used six different modelling strategies across the 240 causes; cause of death ensemble modelling (CODEm) was the dominant strategy for causes with sufficient information. Trends for Alzheimer's disease and other dementias were informed by meta-regression of prevalence studies. For pathogen-specific causes of diarrhoea and lower respiratory infections we used a counterfactual approach. We computed two measures of convergence (inequality) across countries: the average relative difference across all pairs of countries (Gini coefficient) and the average absolute difference across countries. To summarise broad findings, we used multiple decrement life-tables to decompose probabilities of death from birth to exact age 15 years, from exact age 15 years to exact age 50 years, and from exact age 50 years to exact age 75 years, and life expectancy at birth into major causes. For all quantities reported, we computed 95% uncertainty intervals (UIs). We constrained cause-specific fractions within each age-sex-country-year group to sum to all-cause mortality based on draws from the uncertainty distributions. Findings Global life expectancy for both sexes increased from 65·3 years (UI 65·0-65·6) in 1990, to 71·5 years (UI 71·0-71·9) in 2013, while the number of deaths increased from 47·5 million (UI 46·8-48·2) to 54·9 million (UI 53·6-56·3) over the same interval. Global progress masked variation by age and sex: for children, average absolute differences between countries decreased but relative differences increased.For women aged 25-39 years and older than 75 years and for men aged 20-49 years and 65 years and older, both absolute and relative differences increased. Decomposition of global and regional life expectancy showed the prominent role of reductions in age-standardised death rates for cardiovascular diseases and cancers in high-income regions, and reductions in child deaths from diarrhoea, lower respiratory infections, and neonatal causes in low-income regions. HIV/AIDS reduced life expectancy in southern sub-Saharan Africa. For most communicable causes of death both numbers of deaths and age-standardised death rates fell whereas for most non-communicable causes, demographic shifts have increased numbers of deaths but decreased age-standardised death rates. Global deaths from injury increased by 10·7%, from 4·3 million deaths in 1990 to 4·8 million in 2013; but age-standardised rates declined over the same period by 21%. For some causes of more than 100 000 deaths per year in 2013, age-standardised death rates increased between 1990 and 2013, including HIV/AIDS, pancreatic cancer, atrial fibrillation and flutter, drug use disorders, diabetes, chronic kidney disease, and sickle-cell anaemias. Diarrhoeal diseases, lower respiratory infections, neonatal causes, and malaria are still in the top five causes of death in children younger than 5 years. The most important pathogens are rotavirus for diarrhoea and pneumococcus for lower respiratory infections. Country-specific probabilities of death over three phases of life were substantially varied between and within regions. Interpretation For most countries, the general pattern of reductions in age-sex specific mortality has been associated with a progressive shift towards a larger share of the remaining deaths caused by non-communicable disease and injuries. Assessing epidemiological convergence across countries depends on whether an absolute or relative measure of inequality is used. Nevertheless, age-standardised death rates for seven substantial causes are increasing, suggesting the potential for reversals in some countries. Important gaps exist in the empirical data for cause of death estimates for some countries; for example, no national data for India are available for the past decade.

Surveillance report on cardiovascular causes of death in Shouguang, 1993-1997 [寿光市疾病监测点1993～1997年心血管疾病死亡监测报告]

This analysis showed that cardiovascular diseases were the number cause of death claiming 34% of all deaths. More than half (52%) of all cardiovascular deaths were due to Cerebrovascular diseases and about one-third (32%) were due to ischaemic heart disease. The mortality of cardiovascular diseases showed an increasing trend during this period (1993-1997). Abstract in Chinese 心血管疾病是威胁人们健康的重要疾病之一，在居民死因中占主要位置。为了解心血管疾病死亡状况，我们对寿光市农村疾病监测点１９９３～１９９７年居民死亡资料进行了统计分析，现报告如下。（标化死亡率采用１９９０年全国标准人口构成计算）。１９９３～１９９７年监测...

Accuracy of Death Certificates in COPD: Analysis from the TORCH Trial

The Towards a Revolution in COPD Health (TORCH) trial was an international clinical trial of chronic obstructive pulmonary disease (COPD) patients where cause of death was assigned by an independent committee. Comparison of death certificate data and adjudicated cause of death allows a unique opportunity to determine death certificate accuracy and frequency of COPD listing on death certificates of COPD patients. In this analysis, the authors determine the concordance between adjudicated cause of death and primary and secondary cause of death from death certificates. In 317 (80%) of informative deaths, the primary or secondary cause of death from certificates agreed with adjudicated cause of death. Only 229 (58%) of death certificates in these COPD patients listed COPD on the certificate. COPD was not listed on the death certificate in 21% of deaths adjudicated to be caused by COPD exacerbation. Compared with pulmonary causes, the listing of COPD on certificates occurred with less frequency than cardiovascular, cancer and other categories of death. The combined primary and secondary listing on death certificates has good concordance with actual cause of death. COPD is under-reported on death certificates, and this under-reporting is more frequent when the primary cause of death is not pulmonary.

A qualitative exploration of the underlying causes of preventable drug-related morbidity in primary care, resulting in hospitalisation

This study has explored the underlying causes of preventable drug-related admissions to hospital, from primary care through semi-structured interviews and review of patients’ medical records. Analysis of the data has revealed that communication failures between different groups of healthcare professionals and between healthcare professionals and patients contribute to preventable drug-related admissions, as do knowledge gaps about medication in both healthcare professionals and patients. In addition, working conditions for community pharmacists severely limit their ability to effectively act as a safety barrier to patients receiving inappropriate medication. Limitations include heavy workloads, lack of access to patients’ clinical information, poor relationships with general practitioners and time restrictions. The results of this study represent an important addition to our understanding of the contribution of human error as an underlying cause of preventable drug-related morbidity, and the factors which contribute to errors occurring in the primary healthcare setting.

Trends in systemic lupus erythematosus mortality rates in the state of Sao Paulo, Brazil from 1985 to 2004

Objectives To estimate mortality rates and mortality trends from SLE in the state of Sao Paulo, Brazil. Material and methods The official data bank was used to study all deaths occurred from 1985 to 2004 in which SLE was mentioned as the underlying cause of death. Besides the overall mortality rate, the annual gender- and age-specific mortality rates were estimated for each calendar year by age bracket (0-19 years, 20-39 years, 40-59 years and over 60 years) and for the sub-periods 1985-1995 (first) and 1996-2004 (second), by decades. Chi-square test was used to compare the mortality rates between the two periods, as well the mortality rates according to educational level considering years of study. Pearson correlation coefficient test was used to analyse mortality trends. The crude rates were adjusted for age by the direct method, using the standard Brazilian population in 2000. Results A total of 2,601 deaths (90% female) attributed to SLE were analysed. The mean age at death was significantly higher in the second than in the first sub-period (36.6 +/- 15.6 years vs. 33.9 +/- 14.0 years; p<0.001). The overall adjusted mortality rate was 3.8 deaths/million habitants/year for the entire period and 3.4 deaths/million inhabitants/year for the first and 4.0 deaths/million inhabitants/year for the second sub-period (p<0.001). In each calendar year, the mortality rate was significantly lower for the better educated group. Throughout the period, there was a significant increase in mortality rates only among women over 40. Conclusion SLE patients living in the state of Silo Paulo still die at younger ages than those living in developed countries. Our data do not support the theory that there was an improvement in the SLE mortality rate in the last 20 years in the state of Sao Paulo. Socio-economic factors, such as the difficulty to get medical care and adequate treatment, may be the main factors to explain the worst prognosis for our patients.

Causes of death and determinants of outcome in critically ill patients

INTRODUCTION: Whereas most studies focus on laboratory and clinical research, little is known about the causes of death and risk factors for death in critically ill patients. METHODS: Three thousand seven hundred patients admitted to an adult intensive care unit (ICU) were prospectively evaluated. Study endpoints were to evaluate causes of death and risk factors for death in the ICU, in the hospital after discharge from ICU, and within one year after ICU admission. Causes of death in the ICU were defined according to standard ICU practice, whereas deaths in the hospital and at one year were defined and grouped according to the ICD-10 (International Statistical Classification of Diseases and Related Health Problems) score. Stepwise logistic regression analyses were separately calculated to identify independent risk factors for death during the given time periods. RESULTS: Acute, refractory multiple organ dysfunction syndrome was the most frequent cause of death in the ICU (47%), and central nervous system failure (relative risk [RR] 16.07, 95% confidence interval [CI] 8.3 to 31.4, p < 0.001) and cardiovascular failure (RR 11.83, 95% CI 5.2 to 27.1, p < 0.001) were the two most important risk factors for death in the ICU. Malignant tumour disease and exacerbation of chronic cardiovascular disease were the most frequent causes of death in the hospital (31.3% and 19.4%, respectively) and at one year (33.2% and 16.1%, respectively). CONCLUSION: In this primarily surgical critically ill patient population, acute or chronic multiple organ dysfunction syndrome prevailed over single-organ failure or unexpected cardiac arrest as a cause of death in the ICU. Malignant tumour disease and chronic cardiovascular disease were the most important causes of death after ICU discharge.

Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe

Mortality of HIV/tuberculosis (TB) patients in Eastern Europe is high. Little is known about their causes of death. This study aimed to assess and compare mortality rates and cause of death in HIV/TB patients across Eastern Europe and Western Europe and Argentina (WEA) in an international cohort study. Mortality rates and causes of death were analysed by time from TB diagnosis (<3 months, 3-12 months or >12 months) in 1078 consecutive HIV/TB patients. Factors associated with TB-related death were examined in multivariate Poisson regression analysis. 347 patients died during 2625 person-years of follow-up. Mortality in Eastern Europe was three- to ninefold higher than in WEA. TB was the main cause of death in Eastern Europe in 80%, 66% and 61% of patients who died <3 months, 3-12 months or >12 months after TB diagnosis, compared to 50%, 0% and 15% in the same time periods in WEA (p<0.0001). In multivariate analysis, follow-up in WEA (incidence rate ratio (IRR) 0.12, 95% CI 0.04-0.35), standard TB-treatment (IRR 0.45, 95% CI 0.20-0.99) and antiretroviral therapy (IRR 0.32, 95% CI 0.14-0.77) were associated with reduced risk of TB-related death. Persistently higher mortality rates were observed in HIV/TB patients in Eastern Europe, and TB was the dominant cause of death at any time during follow-up. This has important implications for HIV/TB programmes aiming to optimise the management of HIV/TB patients and limit TB-associated mortality in this region.

Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality

Background.  Cryptococcal meningitis is a leading cause of death in people living with human immunodeficiency virus (HIV)/acquired immune deficiency syndrome. The World Health Organizations recommends pre-antiretroviral treatment (ART) cryptococcal antigen (CRAG) screening in persons with CD4 below 100 cells/µL. We assessed the prevalence and outcome of cryptococcal antigenemia in rural southern Tanzania. Methods.  We conducted a retrospective study including all ART-naive adults with CD4 <150 cells/µL prospectively enrolled in the Kilombero and Ulanga Antiretroviral Cohort between 2008 and 2012. Cryptococcal antigen was assessed in cryopreserved pre-ART plasma. Cox regression estimated the composite outcome of death or loss to follow-up (LFU) by CRAG status and fluconazole use. Results.  Of 750 ART-naive adults, 28 (3.7%) were CRAG-positive, corresponding to a prevalence of 4.4% (23 of 520) in CD4 <100 and 2.2% (5 of 230) in CD4 100-150 cells/µL. Within 1 year, 75% (21 of 28) of CRAG-positive and 42% (302 of 722) of CRAG-negative patients were dead or LFU (P<.001), with no differences across CD4 strata. Cryptococcal antigen positivity was an independent predictor of death or LFU after adjusting for relevant confounders (hazard ratio [HR], 2.50; 95% confidence interval [CI], 1.29-4.83; P = .006). Cryptococcal meningitis occurred in 39% (11 of 28) of CRAG-positive patients, with similar retention-in-care regardless of meningitis diagnosis (P = .8). Cryptococcal antigen titer >1:160 was associated with meningitis development (odds ratio, 4.83; 95% CI, 1.24-8.41; P = .008). Fluconazole receipt decreased death or LFU in CRAG-positive patients (HR, 0.18; 95% CI, .04-.78; P = .022). Conclusions.  Cryptococcal antigenemia predicted mortality or LFU among ART-naive HIV-infected persons with CD4 <150 cells/µL, and fluconazole increased survival or retention-in-care, suggesting that targeted pre-ART CRAG screening may decrease early mortality or LFU. A CRAG screening threshold of CD4 <100 cells/µL missed 18% of CRAG-positive patients, suggesting guidelines should consider a higher threshold.

Manual of the international list of causes of death as adopted for use in the United States, based on the fifth decennial revision by the International commission, Paris, October 3-7, 1938. Manual of joint causes of death.

"Prepared by Theodore A. Janssen, chief of the Nosology section."--p.1.

Is mortality from heart failure increasing in Australia? An analysis of official data on mortality for 1997-2003

Objective To assess whether trends in mortality from heart failure(HF) in Australia are due to a change in awareness of the condition or real changes in its epidemiology. Methods We carried out a retrospective analysis of official data on national mortality data between 1997 and 2003. A death was attributed to HF if the death certificate mentioned HF as either the underlying cause of death (UCD) or among the contributory factors. Findings From a total of 907 242 deaths, heart failure was coded as the UCD for 29 341 (3.2%) and was mentioned anywhere on the death certificate in 135 268 (14.9%). Between 1997 and 2003, there were decreases in the absolute numbers of deaths and in the age-specific and age-standardized mortality rates for HF either as UCD or mentioned anywhere for both sexes. HF was mentioned for 24.6% and 17.8% of deaths attributed to ischaemic heart disease and circulatory disease, respectively, and these proportions remained unchanged over the period of study. In addition, HF as UCD accounted for 8.3% of deaths attributed to circulatory disease and this did not change materially from 1997 to 2003. Conclusion The decline in mortality from HF measured as either number of deaths or rate probably reflects a real change in the epidemiology of HF. Population-based studies are required to determine accurately the contributions of changes in incidence, survival and demographic factors to the evolving epidemiology of HF.

Wegener's granulomatosis in Finland in 1981-2000

Objectives: Wegener s granulomatosis (WG) is a vasculitis with a predilection for the airways and kidneys. An increasing incidence and improved prognosis of WG has been shown. The aim of this study was to evaluate the incidence, clinical presentation, diagnostic delay, risk of dialysis-dependent renal insufficiency and mortality of WG in 1981-2000. Patients and methods: Data was retrieved from the Finnish hospital discharge register and hospital case reports. Patients diagnosed with WG in 1981-2000 were included, and their demographic and clinical data recorded. The patients were crossed with the national kidney dialysis register and the national mortality statistics. Results: A total of 492 patients (243 ♂ , 249 ♀) were diagnosed at a mean age of 54 years (SD 18). The incidence increased from 1.9 to 9.3/ million/ year. The median diagnostic delay decreased from 17 to 4 months. Patients presented most often with symptoms of the ear, nose and throat (ENT) (45%), lung (36%), musculoskeletal system (22%) and kidney (11%). Initial lung involvement, constitutional symptoms, high erythrocyte sedimentation rate (ESR) and high ELK scores [(number of simultaneously involved organ groups (ENT, Lung, Kidney)] were associated with a shorter diagnostic delay. Medical treatment of WG patients remained similar in the 1980s and 1990s. Almost 90% of patients received cyclophosphamide (CYC) and more than 90% glucocorticoid medication at some point during the course of the disease. Eighty-four patients (17%) needed dialysis. Initial renal involvement and elevated serum creatinine values were related to an increased risk of dialysis-dependent kidney disease. In two-thirds of the patients, renal impairment was reversible. Dialysis became chronic (>3 months) in 32 patients (6.5%). Nineteen patients (3.9%) received a kidney transplant. Altogether 203 patients (99 men, 104 women) died before 30 June 2005. WG was the underlying cause of death in 37%. The crude one-year and five-year survival rates were 83.3% and 74.2%, respectively. The standardized mortality ratio was 3.43 (95% CI = 2.98 to 3.94). Older age and elevated creatinine level at diagnosis predicted shorter survival. ENT symptoms at presentation and treatment with CYC were associated with better outcome. There was no additional risk associated with male gender or with either of the decades (1981-1990 and 1991-2000) Conclusions: In 1981-2000, the incidence of WG increased ca. 4.5-fold and diagnostic delay decreased to ca. one-fourth, reflecting increased recognition of the disease and improved diagnostic means. WG patients are at great risk of developing dialysis-dependent renal insufficiency and an increased risk of dying. During the study period the treatment of WG did not change markedly, nor did the prognosis improve.

Mortalidade por asma no município do Rio de Janeiro no período de 2000 2009: análise de causas múltiplas

O estudo das causas múltiplas de óbitos permite conhecer a extensão real das estatísticas de mortalidade, minimizando a subestimação dos dados de mortalidade por asma. O objetivo desta pesquisa foi avaliar a tendência das taxas de mortalidade por asma informada em qualquer linha ou parte do atestado médico da declaração de óbito, no município do Rio de Janeiro, no período de 2000-2009. Os dados foram obtidos no Sistema de Informações de Mortalidade (SIM), no período de 2000 a 2009, nas Declarações de Óbitos (DO) registradas com CID-10 J45 e J46, de residentes do município do Rio de Janeiro, com um ano ou mais de idade. Foram calculadas taxas de mortalidade padronizadas por idade, nas seguintes faixas etárias: 1-4 anos, 5-34 anos, 35-59 anos, 60 e mais anos, considerando-se asma como causa básica e como causas múltiplas, segundo gênero para cada ano do período. Para análise de dados foi utilizado a técnica de regressão linear. No período de 10 anos a asma foi causa básica em 67,2% dos óbitos que mencionaram asma. A subestimação da mortalidade por asma como causa básica, foi igual a 48,7%. A taxa de mortalidade padronizada por asma como causa básica declinou de 2000 a 2009 de 2,22 para 1,72/100.000 habitantes em 2009, (β= -0.06, p=0.017) e como causas múltiplas passou de 3,45 para 2,82/100.000 habitantes (β= -0.11, p=0.005). A análise segundo gênero evidenciou um declínio mais acentuado entre os homens, cuja taxa de mortalidade por asma como causa básica padronizada passou de 1,58/100.000 em 2000 para 0,59/100.000 em 2009 (β= -0.08, p=0.007); como causa múltipla a taxa diminuiu de 2,49/100.000 em 2000 para 1,11/100.000 em 2009 (β= -0.14, p<0.00001). Entre as mulheres a taxa de mortalidade passou de 2,79/100.000 em 2000 para 2,72/100.000 em 2009 como causa básica e de 4,29/100.000 em 2000 para 4,32/100.000 em 2009. A regressão linear segmentada, realizada em dois períodos, de 2000 a 2004 e 2004 a 2009, não foi estatisticamente significativa (2000 a 2004: β= -0,16, p=0,131 e 2004 a 2009: β= 0,04, p=0,630). Do total de óbitos nos quais a asma foi mencionada como causa múltipla 2,8% ocorreram na idade de 1 a 4 anos e 61% na faixa de 60 anos e mais. Quando a asma foi causa básica, as causas associadas mais frequentes foram as doenças do aparelho respiratório e nos óbitos em que foi classificada como causa associada destacaram-se como causas básicas as doenças do aparelho respiratório e circulatório. A magnitude das taxas de mortalidade por asma foi sempre maior nas mulheres comparado aos homens. A série histórica mostrou tendência ao declínio nas taxas de mortalidade, segundo causas básicas e múltiplas, com declínio entre os homens e estabilidade entre as mulheres. A mortalidade por asma foi subestimada quando considerada apenas como causa básica, o que poderia ser evitado com a utilização da metodologia de causas múltiplas nas estatísticas de mortalidade da asma.

Anos de vida perdidos por morte prematura por causas externas: análise da tendência e uma proposta metodológica para redistribuição dos códigos-lixo

A violência é considerada uma questão social, ou ainda, um fenômeno social e histórico, que ocorre nas diversas formas de relações humanas e que pode se manifestar em atos individuais ou institucionais, ou seja, realizados por pessoas, grupos, nações, com o objetivo de provocar algum dano físico ou psicológico em outrem. O termo violência, no presente trabalho, refere-se às mortes por causas externas, que incluem as mortes intencionais e as mortes não intencionais, ou seja, agressões, suicídios e acidentes em geral. O objetivo é analisar a evolução da carga de mortalidade no estado do Rio de Janeiro e propor a realocação dos óbitos cuja intenção é indeterminada através de uma nova metodologia. Os dados utilizados são provenientes do Sistema de Informações sobre Mortalidade. Neste estudo, foi utilizado o indicador YLL (Years of Life Lost Anos de Vida Perdidos) na avaliação do comportamento das causas violentas ao longo do tempo, no período de 1996 a 2009, para as macrorregionais de saúde do estado do Rio de Janeiro, através de modelos de efeitos mistos. Foi aplicada a regressão logística multinomial nos óbitos com causa básica conhecida, utilizando as informações como lesões e características individuais das vítimas, para prever qual seria a causa básica de morte nos registros indeterminados com características semelhantes aos óbitos com causas conhecidas. Os resultados encontrados mostram que a violência aumentou em regiões do interior do estado, com destaque para a macrorregional Norte. Na capital e nas regiões metropolitanas, houve uma estabilização das taxas, com exceção para as mortes por agressão que sofreram queda, porém as taxas de YLL permaneceram elevadas. As duas metodologias de realocação, da Carga de Doença e desta nova proposta, aumentam todas as taxas de mortalidade por grupo de causas, porém o grupo que sofreu maior impacto foi o de quedas. Os resultados encontrados, apesar das limitações, apontam para uma proposta de combinação das duas metodologias. Para os óbitos com causa básica de Y10 (Envenenamento [intoxicação] por e exposição a analgésicos, antipiréticos e anti-reumáticos nãoopiáceos, intenção não determinada) a Y33 (Outros fatos ou eventos especificados, intenção não determinada), seria utilizada a metodologia da Carga de Doenças e, para os óbitos de Y34 (Fatos ou eventos não especificados e intenção não determinada), seria utilizado o método proposto.

Análise da mortalidade por causas mal definidas e por diagnósticos incompletos na região do Médio Paraíba, Estado do Rio de Janeiro, de 2005 a 2009

A elevada frequência de óbitos por causas mal definidas e por diagnósticos incompletos compromete a validade de indicadores de mortalidade por causas, constituindo obstáculo para a alocação racional dos recursos de saúde com base em perfil epidemiológico. O presente trabalho avalia a qualidade da informação da causa básica de morte na região do Médio Paraíba, estado do Rio de Janeiro, Brasil, nos anos de 2005 a 2009 para toda a população. Os dados provieram do Sistema de Informações sobre Mortalidade (SIM) disponibilizados pelo DATASUS/MS. A análise baseou-se em dois indicadores de mortalidade proporcional, por causas mal definidas (CMD - todos os óbitos cuja causa básica esteja incluída no capítulo XVIII da CID-10) e por diagnósticos incompletos (DI), segundo classificação apresentada no Projeto Carga de Doença do Brasil, 2002. As associações entre a qualidade da informação e variáveis demográficas, socioeconômicas e relacionadas à ocorrência do óbito foram investigadas por meio do cálculo das razões de chances de mortes por CMD e por DI, em relação às demais causas de morte. Observou-se na região do Médio Paraíba uma proporção de CMD de 4,54% no período de 2005 a 2009. A proporção de diagnósticos incompletos na região do Médio Paraíba no mesmo período mostrou-se elevada (20,59%). Somados os óbitos por CMD e DI na região do Médio Paraíba no quinquênio avaliado, chega-se a uma proporção de causas inadequadamente definidas (25,13%) bem acima do valor mediano de 12% estimado para a população mundial. As chances de CMD e DI decrescem quanto maior o grau de instrução. Quanto à variável raça, os óbitos de indivíduos da raça negra apresentaram maiores chances de ter CMD. Entre os óbitos de indivíduos de cor branca observaram-se maiores chances de constar um DI como causa básica. Nos óbitos sem assistência médica as chances de CMD e DI foram superiores em relação aos óbitos com assistência. Os óbitos em unidade hospitalar apresentaram menores chances de CMD e maiores chances de DI. As variáveis ignoradas ou não informadas apresentaram-se associadas a maiores chances de CMD e DI. Os resultados sugerem que na região do Médio Paraíba a qualidade dos dados de mortalidade no que concerne CMD está bem superior à nacional, assemelhando-se aos valores dos países desenvolvidos. Ainda assim, a proporção de causas residuais encontra-se bastante elevada, evidenciando que não obstante a expressiva melhora do SIM, persistem limitações que restringem a utilização mais ampla do sistema e impedem que os avanços nas políticas e programas na área da saúde sejam maiores.